The landscape is shifting quickly, but medications are supplementing, not replacing, other evidence-based approaches
She has been part of Chronos Virtual Wellness for over two years, where she is passionate about helping patients achieve their weight loss and wellness goals
The malnutrition of obesity: micronutrient deficiencies that promote diabetes
Research suggests that exercise and GLP-1 work together in powerful ways
Considering the evidence, it is no wonder that the Food and Drug Administration (FDA) has approved Ozempic for lowering the cardiovascular event rate in patients with Type 2 diabetes and cardiovascular disease, such as heart disease
Even in patients NOT taking GLP-1s, we see that slow motility can lead to dysbiosis (imbalance of harmful to beneficial bacteria) or SIBO (small intestinal bacterial overgrowth)